Johnson Craig A has filed 11 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 53960 shares of HERON THERAPEUTICS, INC. /DE/ ($HRTX) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Not found | A | Common Stock | 53960 | $0.00 | 53,960.0000 | 183,362,522 | 9999.99% | 0.03% |
| Nov. 21, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Johnson Craig A | Director | F | Common Shares | 6039 | $15.68 | 14,592.0000 | 138,959,000 | 29.27% | 0.00% |
| May 16, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Johnson Craig A | Director | A | Director Stock Option (right to buy) | 37485 | $0.00 | 37,485.0000 | 146,194,000 | 9999.99% | 0.03% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Not found | A | Common Stock | 17950 | $0.00 | 83,770.0000 | 0 | 27.27% | 0.00% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Not found | A | Stock Option (Right to Buy) | 35900 | $0.00 | 35,900.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Not found | A | Stock Option (Right to Buy) | 35900 | $1.73 | 35,900.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Not found | A | Common Stock | 17950 | $0.00 | 83,770.0000 | 0 | 27.27% | 0.00% |
| Nov. 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Johnson Craig A | Director | A | Director Stock Option (right to buy) | 31688 | $0.00 | 31,688.0000 | 145,651,000 | 9999.99% | 0.02% |
| Nov. 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Johnson Craig A | Director | A | Common Shares | 20631 | $0.00 | 20,631.0000 | 145,651,000 | 9999.99% | 0.01% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Director | A | Common Stock | 13948 | $0.00 | 65,820.0000 | 0 | 26.89% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Johnson Craig A | Director | A | Stock Option (Right to Buy) | 83685 | $0.00 | 83,685.0000 | 0 | 9999.99% | 0.00% |